Diabetes Guidelines and Medications Flashcards
AAFP Board Review lecture: Diabetes ADA guidelines 2021
Who to screen for diabetes if asymptomatic?
Obese or overweight adults and/or with one or more risk factors (esp. if planning for pregnancy)
Test everyone at age 45, repeat q3 years if normal
Overweight, obese children (after puberty or after age 10) who have risk factors
How often should patients with prediabetes, Impaired glucose tolerance or Impaired fasting glucose be tested?
Yearly
How often should women diagnosed with a history of GDM be tested?
Every 3 years for life
Risk factors for DM?
- Overweight/Obesity (BMI >= 25)
- Acanthosis nigricans
- 1st degree relative with DM
- Latino, African American, Native American, Asian, Pacific Islander
- Hx of CVD
- HTN (controlled or not)
- Women with PCOS
- HIV
Prediabetes A1c, fasting and 2hr glucose levels?
A1c: 5.7-6.4%
Fasting glucose: 100-125
2 hr 75g OGTT: 140-199
Diabetes A1c, fasting, 2hr and random glucose levels?
A1c: >= 6.5
Fasting: >= 126
2 hr 75g OGTT: >=200
Random: >= 200
Per USPTF guidelines, What is the weight loss and activity goal for intensive lifestyle behavior change in managing diabetes?
Achieve and maintain 7% loss of initial body weight
Increase moderate-intensity physical activity (such as brisk walking) for at least 150 minutes/ week. (20 mintues per day)
Who should get metformin for DM prevention?
prediabetes with risk factors:
BMI >= 35
60 years and older
women with prior GDM
Risk factors of DM for asymptomatic children/adolescents?
overweight/obese and:
- hx of maternal DM or GDM during gestation
- 1st or 2nd degree family hx
- Latino, African American, Native American, Asian, Pacific Islander
- Signs of insulin resistance or associated conditions (acanthosis nigricans, hypertension, dyslipidemia, PCOS or small-for-gestational-age birth weight
Physical activity goals for children with T1 or T2 DM?
60 minutes/day or more of moderate/vigorous aerobic activity
vigorous muscle and bone strengthening activities at least 3 days/week.
Physical activity goals for adults with T1 or T2 DM?
150 minutes or more of moderate- to vigorous-intensity aerobic activity per week, spread over at least 3 days/week, with no more than 2 consecutive days without activity.
Exercise restrictions to consider in patients with diabetes complications?
Proliferative retinopathy- may trigger vitreous hemorrhage
Peripheral Neuropathy- Proper foot wear, good daily foot exams, NWB if open sore/injury
Autonomic Neuropathy- needs cardiac investigation prior to starting more intense exercise
How often to check A1c (or other gylcemic measurement) in patients with DM?
Stable control: every 6 months
uncontrolled or recent change in therapy: every 3 months
Gylcemic Goal for nonpregnant adults
<6.5%: new diagnosis, long life expectancy
<8%: long standing disease, advanced complications
<8.5%: limited life expectancy, complex elderly patients
Who needs less stringent A1c?
<8% long standing disease, advanced complications
<8.5% if limited life expectancy, harms > benefits, complex older adults, nursing home
Hypoglycemia levels
Level 1: <70
Level 2: <54
Level 3: Severe event, AMS
-Give patients with a history of level 2 or 3 hypogylcemic events a prescription for glucagon
Preferred initial treatment of Type II DM?
Metformin
Continue as long as tolerated and not contraindicated
When to start early initiation of insulin?
Evidence of ongoing catabolism (weight loss)
Symptoms of hyperglycemia
A1C levels >10%
Blood glucose levels >=300
BP goal for patient with DM and existing ASCVD or ASCVD risk >15%?
<130/80
BP goal for patient with DM and low CVD risk (ASCVD <15%)?
<140/90
First line HTN treatment for patients with DM and CAD?
ACEi or ARB -Monitor Cr/GFR, K at least annually
What population should get GLP-1 receptor agonists and why?
Patients with type 2 diabetes and established ASCVD or multiple risk factors for ASCVD CV benefit is recommended to reduce the risk of MACE
What population should get SGLT2 inhibitors and why? (2)
Patients with T2DM and ASCVD, multiple ASCVD risk factors, or Diabetic kidney disease
Reduce risk of worsening HF and CV death in patients with type 2 diabetes and established HFrEF
For patients with ASCVD, esp. CAD, why is ACEi/ARB recommended?
Reduce the risk of CV events
How long should patients with prior MI continue BB?
3 years after the event
Can patients with HF continue metformin?
Yes, if stable HF and GFR >30 No, if unstable or hospitalized
How to screen for CKD in T1 and T2 DM patients?
T1 >5 years, screen annually
T2: annually screen with urinary albumin and GFR
If urine albumin >300 or GFR 30-60, monitor twice per year
Describes some renal benefits of GLP-1 receptor agonists
reduces renal end points, primarily albuminuria, progression of albuminuria, and CV events
Which DM patients should get and ACEi/ARB?
nonpregnant with DM and HTN:
Moderate recommendation: UACr 20-299
Strong rec: UACr >300, GFR <60
Not for primary prevention in non-HTN and normal UACr and GFR patients
When to refer DM patients to Nephrology?
GFR <30
Eitology unknown
Management issues
Rapidly progressing disease
How often to screen for diabetic retinopathy?
T2: At time of diagnosis then yearly
T1: 5 years after diagnosis the yearly
In patients with diabetic retinopathy should ASA be discontinued?
The presence of retinopathy is not a contraindication to aspirin therapy for cardioprotection, as aspirin does not increase the risk of retinal hemorrhage
How to screen for diabetic neuropathy?
History
temperature or pinprick sensation (small fiber testing) and vibration sensation using a 128-Hz tuning fork (large fiber testing)
annual 10-g monofilament testing
When to refer DM patients to podiatry/foot specialist?
Smokers
Hx of prior lower-extremity complications, PAD
loss of protective sensation, structural abnormalities
When to get ABI or vascular eval?
Patients with symptoms of claudication or decreased/absent pedal pulses
History to obtain for DM foot care?
Obtain a prior history of ulceration, amputation, Charcot foot, angioplasty or vascular surgery, cigarette smoking, retinopathy, and renal disease
Assess current symptoms of neuropathy (pain, burning, numbness) and vascular disease (leg fatigue, claudication).
A1c goals for elderly patients?
Older adults who are otherwise healthy with few coexisting chronic illnesses and intact cognitive function and functional status should have lower glycemic goals (such as A1C <7.0–7.5%)
Those with multiple coexisting chronic illnesses, cognitive impairment, or functional dependence should have less stringent glycemic goals (such as A1C <8.0–8.5%)
Considerations for elderly patients with DM
Increased risk of hypoglycemia, medication classes with low risk of hypoglycemia are preferred.
Overtreatment/complex regiments are common - simplfy medications
Physical activity, weight loss, diet as tolerated
Considerations for preconception care in patients with DM: A1c goal and DM risks? Who should be apart of the multidisciplinary team?
Preconception counseling: address the importance of achieving glucose levels as close to normal as is safely possible, ideally A1C <6.5%, to reduce the risk of congenital anomalies, preeclampsia, macrosomia, preterm birth, and other complications.
Women with preexisting diabetes who are planning a pregnancy should ideally be managed beginning in preconception in a multidisciplinary clinic including an endocrinologist, maternal-fetal medicine specialist, RD/RDN, and CDCES, when available.
Treatment and medications to avoid for pregnant women with DM
Insulin is the preferred medication for treating hyperglycemia in GDM.
Metformin and glyburide should not be used as first-line agents, as both cross the placenta to the fetus.
Other oral and non- insulin injectable glucose-lowering medications lack long-term safety data.
Postpartum care in women with hx of GDM? (3)
Screen at 4–12 weeks postpartum, using the 75-g oral glucose tolerance test
Lifestyle interventions +/- metformin
Screen for DM every 1-3 years
Should A1c be tested in hospitalized patients with DM?
A1C test on all patients with diabetes or hyperglycemia (blood glucose >140) admitted to the hospital if not performed in the prior 3 months
Glycemic target for hospitalized patients with DM
Start insulin if BG persistently >180
Goal 140-80 (110-140 if achieved with no hypogylcemia)
How do insulin requirements change in the first few days postpartum?
Insulin resistance decreases dramatically immediately postpartum, and insulin requirements need to be evaluated and adjusted, as they are often roughly half the pre-pregnancy requirements for the initial few days postpartum
BP goals for pregnant women with DM and HTN?
110–135/ 85 mmHg
No ACEi/ARBs or statins
Diabetic retinopathy screening in women with preexisting type 1 or type 2 diabetes who are planning pregnancy or who have become pregnant?
Counsel on the risk of development and/or progression of diabetic retinopathy.
Dilated eye examinations should occur ideally before pregnancy or in the first trimester, and then patients should be monitored every trimester and for 1 year postpartum as indicated
Name a biguanide and the dose
Metformin
1000mg BID or 2000mg daily XR
(Titrate up 1 tab per week)
Max effect is at 2 g daily
What is the MOA of metformin?
Decreases gluconeogenesis in the liver (dec glucose production)
Decreases intestinal absorption of glucose
Improves insulin sensitivity
Increases peripheral glucose uptake and used
Name the contraindications of Metformin (3)
If GFR <30 don’t use/stop
If GFR 30-45 don’t start, if already on decrease dose by 50%
If patient has risk of lactic acidosis:
-unstable CHF exacerbation, DKA, shock, metabolic acidosis, hepatic impairment
List the side effects of Metformin
Diarrhea, GI upset (IR > ER)
Ghost pills
B12 deficiency
How much does Metformin lower A1c?
1.5-2%
How should you manage the risk of B12 deficiency with Metformin?
Shared decision making:
1) Start B12 supplement ppx
2) Monitor B12 levels every few years then treat as needed
*B12 deficiency can cause neuropathy*
What symptoms does lactic acidosis present with?
Flu-like symptoms
Name 2 thiazolidinediones (TZD)
Pioglitazone (Actos), 15 or 30 mg (rarely 45 mg)
Rosiglitazone (Avandia) [not used much in USA]
What is the MOA of TZDs?
Activate PPAR-g
Acts on adipose to increase *insulin sensitivity*
Acts on muscles to increase glucose use
What are the contraindications of TZDs? (4)
CHF NYHA class II or greater (not great for patients with CAD either)
Liver failure
Bladder Cancer: personal or family history
Osteoporosis (increased fracture risk, use with caution)
Cat C in pregnancy
What are the side effects of TZDs?
Weight gain
Edema
Fractures
What should you monitor in patiets taking a TZD?
LFTs prior to starting and during treatment
Weight, volume status
Symptoms of bladder cancer
How much do TZDs lower A1c?
About 1%
Name 3 SGLT-2 inhibitors and doses
Canagliflozen (Invokana) 100- 300 mg daily
Empagliflozen (Jardiance) 10-25 mg daily
Dapagliflozen (Farxiga) 10 mg daily
MOA of SGLT-2 inhibitors
Block glucose reabsorption in proximal convuluted tubule
Increase glucose secretion
Contraindications for SGLT-2 inhibitors
Type 1 DM
Hx of DKA
Severe hepatic impairment (Invokana)
GFR < 30
What medications make up Invokamet XR/Xigduo XR/Synjardy XR?
metformin and an SGLT-2 inhibitor
How to renally dose SGLT-2 inhibitors?
Treat all patients with DM, CKD and GFR >30 with an SGLT-2 inhibitor
*Adjust other medications (except metformin) to accomodate SGLT-2 inhibitors
If GFR <30 do not start this med
*If already on this med and GFR falls below 30, can continue until dialysis